These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 2747287)
1. Does the site of the breakpoint on chromosome 22 influence the duration of the chronic phase in chronic myeloid leukemia? Birnie GD; Mills KI; Benn P Leukemia; 1989 Aug; 3(8):545-7. PubMed ID: 2747287 [No Abstract] [Full Text] [Related]
2. Remarkably long survival of a patient with Ph1-positive chronic myeloid leukemia and 5' bcr rearrangement. Johansson B; Mertens F; Fioretos T; Heim S; Kristoffersson U; Mandahl N; Bartram CR; Mitelman F Leukemia; 1990 Jun; 4(6):448-9. PubMed ID: 2359344 [TBL] [Abstract][Full Text] [Related]
3. bcr-abl mRNA lacking abl exon a2 detected by polymerase chain reaction in a chronic myelogeneous leukemia patient. van der Plas DC; Soekarman D; van Gent AM; Grosveld G; Hagemeijer A Leukemia; 1991 Jun; 5(6):457-61. PubMed ID: 2056770 [TBL] [Abstract][Full Text] [Related]
4. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia. Prejzner W Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769 [TBL] [Abstract][Full Text] [Related]
5. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia. Eisenberg A; Silver R; Soper L; Arlin Z; Coleman M; Bernhardt B; Benn P Leukemia; 1988 Oct; 2(10):642-7. PubMed ID: 3172841 [TBL] [Abstract][Full Text] [Related]
6. Complex variant Philadelphia translocation involving the short arm of chromosome 9 in a case of chronic myeloid leukemia. Cianciulli AM; Marzano R; Merola R; Orlandi G; Petti MC; Guadagni F; Pisani F Haematologica; 2004 Sep; 89(9):ECR37. PubMed ID: 15377489 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of a CML patient with a long duration of chronic phase before and after lymphoid blast crisis. Price CM; Foadi MD; Morgan GJ; Wiedemann LM Leukemia; 1990 Jun; 4(6):455-7. PubMed ID: 2359347 [TBL] [Abstract][Full Text] [Related]
8. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients. Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454 [TBL] [Abstract][Full Text] [Related]
9. Further evidence that the site of the breakpoint in the major breakpoint cluster region (M-bcr) may be a prognostic indicator. Mills KI; Hynds SA; Burnett AK; MacKenzie ED; Birnie GD Leukemia; 1989 Dec; 3(12):837-40. PubMed ID: 2685475 [TBL] [Abstract][Full Text] [Related]
10. Translocation 3;21 in Philadelphia chromosome positive chronic myeloid leukemia at diagnosis. Thompson PW; Whittaker JA Cancer Genet Cytogenet; 1989 Jun; 39(2):143-6. PubMed ID: 2752367 [TBL] [Abstract][Full Text] [Related]
11. Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia. Fioretos T; Nilsson PG; Aman P; Heim S; Kristoffersson U; Malm C; Simonsson B; Turesson I; Mitelman F Leukemia; 1993 Aug; 7(8):1225-31. PubMed ID: 8350622 [TBL] [Abstract][Full Text] [Related]
12. The relationship of bone marrow histology with the molecular pattern in chronic myeloid leukemia. Vigorito AC; Lorand-Metze I; Chauffaile ML; Costa FF; Saad ST Haematologia (Budap); 1998; 29(2):123-32. PubMed ID: 9728804 [TBL] [Abstract][Full Text] [Related]
13. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response. Agirre X; Fontalba A; Andreu EJ; Odero MD; Larráyoz MJ; Montiel C; Calasanz MJ; Fernández-Luna JL; Prósper F Haematologica; 2003 Dec; 88(12):1425-6. PubMed ID: 14687999 [No Abstract] [Full Text] [Related]
14. Sequestration of Philadelphia chromosome-positive cells in the bone marrow of a chronic myeloid leukemia patient in very prolonged remission. Birnie GD; MacKenzie ED; Goyns MH; Pollock A Leukemia; 1990 Jun; 4(6):452-4. PubMed ID: 2359346 [No Abstract] [Full Text] [Related]
15. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia. Inoue T; Tojo A; Tsuchimoto D; Okamoto S; Ogura H; Tani K; Ozawa K; Shibuya M; Asano S Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306 [TBL] [Abstract][Full Text] [Related]